OTCMKTS:GBLXGB Sciences Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding GB Sciences Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.03 0.00 (0.00 %) (As of 07/13/2020 09:46 AM ET) Add Compare Share Today's Range$0.03Now: $0.03▼$0.0450-Day Range$0.03MA: $0.03▼$0.0452-Week Range$0.02Now: $0.03▼$0.15Volume151,800 shsAverage Volume362,903 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media GB Sciences, Inc. focuses to be a technology and solution company that converts the cannabis plant into medicines, therapies, and treatments for various ailments. The company is developing technologies in plant biology, cultivation and extraction techniques, which are combined with biotechnology; and plans to produce medical-grade cannabis, cannabis concentrates, and cannabinoid therapies. GB Sciences, Inc. has an agreement with Growblox Sciences, Puerto Rico, LLC that grants the right to its technology and intellectual property. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for GB Sciences. Previous Next 2.5 Community Rank Outperform VotesGB Sciences has received 96 “outperform” votes. (Add your “outperform” vote.)Underperform VotesGB Sciences has received 97 “underperform” votes. (Add your “underperform” vote.)Community SentimentGB Sciences has received 50.26% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about GB Sciences and other stocks. Vote “Outperform” if you believe GBLX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe GBLX will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldGB Sciences does not currently pay a dividend.Dividend GrowthGB Sciences does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, GB Sciences insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.50 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Biotechnology Sub-IndustryCannabis SectorMedical Current SymbolOTCMKTS:GBLX Previous Symbol CUSIPN/A CIK1165320 Webgbsciences.com Phone+1-888-8953594Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees60 Outstanding SharesN/AMarket CapN/A Next Earnings Date8/13/2020 (Estimated) OptionableNot Optionable OTC:GBLX Rates by TradingView Receive GBLX News and Ratings via Email Sign-up to receive the latest news and ratings for GBLX and its competitors with MarketBeat's FREE daily newsletter. GB Sciences (OTCMKTS:GBLX) Frequently Asked Questions How has GB Sciences' stock been impacted by COVID-19 (Coronavirus)? GB Sciences' stock was trading at $0.03 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, GBLX stock has increased by 0.0% and is now trading at $0.03. View which stocks have been most impacted by Coronavirus. When is GB Sciences' next earnings date? GB Sciences is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for GB Sciences. How were GB Sciences' earnings last quarter? GB Sciences Inc (OTCMKTS:GBLX) released its quarterly earnings data on Monday, November, 14th. The company reported ($0.04) earnings per share for the quarter. View GB Sciences' earnings history. Has GB Sciences been receiving favorable news coverage? News coverage about GBLX stock has trended very negative on Monday, InfoTrie Sentiment reports. The research group ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. GB Sciences earned a media sentiment score of -3.2 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about GB Sciences. Who are some of GB Sciences' key competitors? Some companies that are related to GB Sciences include Canopy Growth (WEED), Canopy Growth (CGC), Innovative Industrial Properties (IIPR), OrganiGram (OGI), GrowGeneration (GRWG), Emblem (EMC), ICC Labs (ICC), Bioventix (BVXP), 22nd Century Group (XXII), KushCo (KSHB), General Cannabis (CANN), Nemus Bioscience (NMUS), Terra Tech (TRTC), mCig (MCIG) and Grow Capital (GRWC). View all competitors. What other stocks do shareholders of GB Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other GB Sciences investors own include Amplify Energy (AMPY), Amplify Energy (AMPY), InMed Pharmaceuticals (IMLFF), KushCo (KSHB), mCig (MCIG), Medical Marijuana (MJNA), MassRoots (MSRT), Surna (SRNA), Marimed (MRMD) and PotNetwork (POTN). Who are GB Sciences' key executives? GB Sciences' management team includes the following people: Mr. John C. Poss, Chairman & CEO (Age 71)Ms. Ksenia Griswold, COO, CFO, VP & Controller (Age 36)Dr. Andrea Small-Howard M.B.A., Ph.D., MBA, Chief Science Officer & Director (Age 50)Mr. Krin Ellery Kuethe, Sr. VP of Cultivation (Age 35)Mr. John B. Davis, Gen. Counsel & Exec. VP What is GB Sciences' stock symbol? GB Sciences trades on the OTCMKTS under the ticker symbol "GBLX." How do I buy shares of GB Sciences? Shares of GBLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is GB Sciences' stock price today? One share of GBLX stock can currently be purchased for approximately $0.03. What is GB Sciences' official website? The official website for GB Sciences is gbsciences.com. How can I contact GB Sciences? GB Sciences' mailing address is 6450 Cameron St Ste 110A, LAS VEGAS, NV 89118-4337, United States. The company can be reached via phone at +1-888-8953594. This page was last updated on 7/13/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
